公开(公告)号：TR200102277T2

公开(公告)日：2002-01-21

申请号：TR200102277

申请日：1999-11-04

Applicant: BASF AG AG

Inventor： DOYLE KEVIN J ,  RAFFERTY PAUL ,  STEELE ROBERT W ,  WILKINS DAVID J ,  HOCKLEY MICHAEL ,  ARNOLD LEE D ,  ERICSSON ANNA M

IPC: A61K31/416 ,  A61K31/4162 ,  A61K31/4427 ,  A61K31/4433 ,  A61K31/4439 ,  A61P1/04 ,  A61P1/16 ,  A61P5/14 ,  A61P7/10 ,  A61P9/00 ,  A61P9/10 ,  A61P11/00 ,  A61P15/08 ,  A61P17/02 ,  A61P17/06 ,  A61P19/02 ,  A61P19/08 ,  A61P27/00 ,  A61P27/06 ,  A61P35/00 ,  A61P37/00 ,  A61P43/00 ,  C07D231/54 ,  C07D401/04 ,  C07D401/12 ,  C07D403/12 ,  C07D409/04 ,  C07D413/04 ,  C07D417/12 ,  C07D491/04 ,  C07D491/048 ,  C07D495/04 ,  A61K31/415 ,  A61K31/425 ,  A61K31/44 ,  A61K31/445

Abstract: This invention relates to certain 3-aryl or 3-heteroaryl pyrazoles with 4,5(3,4)-bicyclic ring fusion which are inhibitors of protein kinase activity, of which some are novel compounds, to pharmaceutical compositions containing these pyrazoles and to processes for preparing these pyrazoles.